Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims

NCT06659744 · clinicaltrials.gov ↗

COMPLETED

Status

158310

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: New use of semaglutide injection
DRUG: New initiation of sitagliptin

Sponsor

Brigham and Women's Hospital